for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

Posted

The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent. Conway G. Gittens has more.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up